Cardiometabolic Outcomes Among Adults With Abdominal Obesity and Normal Body Mass Index
Kedir Y. Ahmed(Charles Sturt University), Allen G. Ross(Charles Sturt University), Getiye Dejenu Kibret(University of Technology Sydney), Desalegn Markos Shifti(The University of Queensland), Asres Bedaso(Cancer Council NSW), Meless G. Bore(Hawassa University), Zemenu Yohannes Kassa(University of Technology Sydney), Zekariyas Sahile(Charles Sturt University), Feleke Hailemichael Astawesegn(Charles Sturt University), Subash Thapa(Charles Sturt University), Sewunet Admasu Belachew(The University of Queensland), Utpal K. Mondal(Charles Sturt University), Abel Fekadu Dadi, Daniel Bekele Ketema(UNSW Sydney), Fentaw Tadese(Griffith University), Abdulbasit Seid(Monash University), Addisu Shunu Beyene, Teketo Kassaw Tegegne(Deakin University), Shakeel Mahmood(Charles Sturt University), Cheru Tesema Leshargie(Charles Sturt University), Mohd. Farooq Shaikh(Monash University Malaysia), Aklilu Habte Hailegebireal(Wachemo University), Bereket Duko(Curtin University), Setognal Birara Aychiluhm(University of Gondar), Kasuni Akalanka Hewa Marambage(Charles Sturt University), Habtamu Mellie Bizuayehu(The University of Queensland)
Cited by 16
Related Papers
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015
|The Lancet|2017|2.1k
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Infectious Diseases|2018|2k
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Infectious Diseases|2018|1.5k
Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet Infectious Diseases|2017|1.4k
A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness
|International Journal of Infectious Diseases|2020|302